Skip to main content
Top
Published in: Abdominal Radiology 2/2019

01-02-2019

Lower energy levels and iodine-based material decomposition images increase pancreatic ductal adenocarcinoma conspicuity on rapid kV-switching dual-energy CT

Authors: Serdar Aslan, Ilkay Camlidag, Mehmet Selim Nural

Published in: Abdominal Radiology | Issue 2/2019

Login to get access

Abstract

Purpose

Multidetector computed tomography (MDCT) is used in the diagnosis of pancreatic ductal adenocarcinoma (PDAC), but it may be inadequate in some cases. Tumor detection can be improved using rapid kV-switching dual-energy CT (rsDECT) and iodine maps. Our aim this study is to evaluate tumor conspicuity in PDAC cases using rsDECT and iodine maps.

Methods

Ninety cases with PDAC were evaluated rsDECT. Tumor contrast (HU) differences, tumor size, CNR (contrast-noise ratio), and noise were measured at 70 keV, individual CNR-energy level, and 45 keV, respectively. Quantitative differences in contrast gain ∆70-CNR and ∆CNR-45 were compared. On iodine maps, the iodine concentration measured in the tumor and parenchyma was normalized to the aorta as normalized iodine concentration (NIC) and compared.

Results

The median optimized viewing energy level was 51 keV. The mean ± SD tumor contrast values were 62 ± 20, 115 ± 48, and 152 ± 48 HU (p < 0.001); the largest axial diameters were 36.6 ± 5.1, 37.9 ± 4.2, and 38.3 ± 3.7 mm (p = 0.015); the CNRs were 1.83 ± 0.72, 3.37 ± 0.93, and 2.36 ± 0.56; and the image noise levels were 23.7 ± 6.8, 39.3 ± 11.6, and 59.5 ± 17.2 (p < 0.001) (p < 0.001) for 70 keV, optimized energy level, and 45 keV, respectively. The mean ± SD contrast gain ∆70-CNR was 63 ± 12; and ∆CNR-45 was 31 ± 26 HU (p < 0.001). NICtumor and NICparenchyma values were 0.62 ± 0.03 and 1.36 ± 0.05 mg/mL, respectively (p = 0.004).

Conclusion

The use of low energy levels on rsDECT and iodine maps improves tumor conspicuity. This situation may be help better detection of pancreatic tumors.
Literature
1.
go back to reference American Cancer Society (2013) Cancer facts and figures. Atlanta: American Cancer Society American Cancer Society (2013) Cancer facts and figures. Atlanta: American Cancer Society
2.
go back to reference Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921CrossRefPubMed Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921CrossRefPubMed
3.
go back to reference Sahani DV, Shah ZK, Catalano OA, Boldan GW, Brugge WR (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23:23–33CrossRefPubMed Sahani DV, Shah ZK, Catalano OA, Boldan GW, Brugge WR (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23:23–33CrossRefPubMed
4.
go back to reference Klauss M, Stiller W, Pahn G, et al. (2013) Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol 82:208–214CrossRefPubMed Klauss M, Stiller W, Pahn G, et al. (2013) Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol 82:208–214CrossRefPubMed
5.
go back to reference Callery MP, Chang KJ, Fishman EK, et al. (2009) Pretreatment assessment of resectable or borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed Callery MP, Chang KJ, Fishman EK, et al. (2009) Pretreatment assessment of resectable or borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed
6.
go back to reference Grözinger G, Grözinger A, Horger M (2014) The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Fortschr Röntgenstr 186:1082–1093CrossRef Grözinger G, Grözinger A, Horger M (2014) The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Fortschr Röntgenstr 186:1082–1093CrossRef
7.
go back to reference Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. Am J Roentgenol 82:897–903CrossRef Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. Am J Roentgenol 82:897–903CrossRef
8.
go back to reference Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB (2002) Isoattenuating pancreatic adenocarcinoma at multi–detector row CT: secondary signs. Radiology 224:764–768CrossRefPubMed Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB (2002) Isoattenuating pancreatic adenocarcinoma at multi–detector row CT: secondary signs. Radiology 224:764–768CrossRefPubMed
9.
go back to reference Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96CrossRefPubMed Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96CrossRefPubMed
10.
go back to reference Macari M, Spieler B, Kim D, et al. (2010) Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and at simulated weighted-average 120 kVp. Am J Roentgenol 194:27–32CrossRef Macari M, Spieler B, Kim D, et al. (2010) Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and at simulated weighted-average 120 kVp. Am J Roentgenol 194:27–32CrossRef
11.
go back to reference Graser A, Johnson TR, Chandarana H, Macari H (2009) Dual-energy CT: preliminary observations and potential clinical applications in the abdomen. Eur Radiol 19:13–23CrossRefPubMed Graser A, Johnson TR, Chandarana H, Macari H (2009) Dual-energy CT: preliminary observations and potential clinical applications in the abdomen. Eur Radiol 19:13–23CrossRefPubMed
12.
go back to reference Johnson TR, Krauss B, Sedlmair M, et al. (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517CrossRefPubMed Johnson TR, Krauss B, Sedlmair M, et al. (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517CrossRefPubMed
13.
go back to reference Fletcher JG, Takahashi N, Hartman R, et al. (2009) Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am 47:41–57CrossRefPubMed Fletcher JG, Takahashi N, Hartman R, et al. (2009) Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am 47:41–57CrossRefPubMed
14.
go back to reference Patel BN, Thomas JV, Lockhart ME, Berland LL, Morgan DE (2013) Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast. Clin Radiol 68:148–154CrossRefPubMed Patel BN, Thomas JV, Lockhart ME, Berland LL, Morgan DE (2013) Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast. Clin Radiol 68:148–154CrossRefPubMed
15.
go back to reference Flohr TG, McCollough CH, Bruder H, et al. (2006) First performance evaluation of a dual source CT (DSCT) system. Eur Radiol 16:256–268CrossRefPubMed Flohr TG, McCollough CH, Bruder H, et al. (2006) First performance evaluation of a dual source CT (DSCT) system. Eur Radiol 16:256–268CrossRefPubMed
16.
go back to reference McNamara MM, Little MD, Alexander LF, et al. (2015) Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT. Abdom Imaging 40(5):1230–1240CrossRefPubMed McNamara MM, Little MD, Alexander LF, et al. (2015) Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT. Abdom Imaging 40(5):1230–1240CrossRefPubMed
17.
go back to reference Lu DSK, Vedantham S, Krasny RM, et al. (1996) Two phase helical CT for pancreatic tumours: pancreatic versus hepatic phase enhancement of tumour, pancreas and vascular structures. Radiology 199:697–701CrossRefPubMed Lu DSK, Vedantham S, Krasny RM, et al. (1996) Two phase helical CT for pancreatic tumours: pancreatic versus hepatic phase enhancement of tumour, pancreas and vascular structures. Radiology 199:697–701CrossRefPubMed
Metadata
Title
Lower energy levels and iodine-based material decomposition images increase pancreatic ductal adenocarcinoma conspicuity on rapid kV-switching dual-energy CT
Authors
Serdar Aslan
Ilkay Camlidag
Mehmet Selim Nural
Publication date
01-02-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1754-2

Other articles of this Issue 2/2019

Abdominal Radiology 2/2019 Go to the issue